Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
Shloush J, Vlassov JE, Engson I, Duan S, Saridakis V, Dhe-Paganon S, Raught B, Sheng Y, Arrowsmith CH.
J Biol Chem. 2011 Feb 11;286(6):4796-808. Epub 2010 Nov 17.
Related citations
Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR, Lim JH, Choi Y, Kim DG, Kang KJ, Noh SM, Im DS.
J Clin Invest. 2010 Dec;120(12):4493-506. doi: 10.1172/JCI42674. Epub 2010 Nov 8.
Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.
Nie J, Xie P, Liu L, Xing G, Chang Z, Yin Y, Tian C, He F, Zhang L.
J Biol Chem. 2010 Jul 23;285(30):22818-30. Epub 2010 May 18.
Mdm2 facilitates the association of p53 with the proteasome.
Kulikov R, Letienne J, Kaur M, Grossman SR, Arts J, Blattner C.
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10038-43. Epub 2010 May 17.
Ribosomal protein S7 is both a regulator and a substrate of MDM2.
Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X, Prives C.
Mol Cell. 2009 Aug 14;35(3):316-26.
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
Okamoto K, Taya Y, Nakagama H.
FEBS Lett. 2009 Sep 3;583(17):2710-4. Epub 2009 Jul 18.
FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.
Ochocka AM, Kampanis P, Nicol S, Allende-Vega N, Cox M, Marcar L, Milne D, Fuller-Pace F, Meek D.
FEBS Lett. 2009 Feb 18;583(4):621-6. Epub 2009 Jan 21.
Specific inhibition of Mdm2-mediated neddylation by Tip60.
Dohmesen C, Koeppel M, Dobbelstein M.
Cell Cycle. 2008 Jan 15;7(2):222-31. Epub 2007 Oct 16.
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA.
Cancer Cell. 2007 Oct;12(4):342-54.
Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
Singh RK, Iyappan S, Scheffner M.
J Biol Chem. 2007 Apr 13;282(15):10901-7. Epub 2007 Feb 14.
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.
Kostic M, Matt T, Martinez-Yamout MA, Dyson HJ, Wright PE.
J Mol Biol. 2006 Oct 20;363(2):433-50. Epub 2006 Aug 14.
Critical role for Daxx in regulating Mdm2.
Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, Degenhardt YY, El-Deiry WS, Yang X.
Nat Cell Biol. 2006 Aug;8(8):855-62. Epub 2006 Jul 16.
Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS, Shi D, Jin Y, Sun XX, Zhang Y, Grossman SR, Lu H.
J Biol Chem. 2006 Aug 25;281(34):24304-13. Epub 2006 Jun 27.
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O.
Hum Mol Genet. 2006 Jul 1;15(13):2059-75. Epub 2006 May 19.
The ubiquitin-protein ligase activity of Hdm2 is inhibited by nucleic acids.
Linares LK, Scheffner M.
FEBS Lett. 2003 Nov 6;554(1-2):73-6.
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM.
J Biol Chem. 2000 Mar 24;275(12):8945-51.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on